George Green, Head of Pharmacodiagnostics at Bristol Meyers Squibb, joins Beyond the Scope to discuss the pharmaceutical industry's perspective on digital pathology and artificial intelligence. The conversation revolves around how digital pathology will see increased applications in the current era of precision medicine.

1:22 Introduction
4:15 The companion diagnostics revolution in pharma
9:54 Early applications of digital pathology in pharma
14:38 How the mindset of pathologists has evolved since the dawn of DP/AI
19:55 Pharma perspective on how DP/AI will drive the future of precision medicine
25:00 Increasing DP adoption in the pharma industry
28:40 Digital pathology bringing better patient care around the world

A forum to engage with the hosts and other listeners has been launched on the DPA website www.digitalpathologyassociation.org. DPA members may login to the DPA Collaborate hub (under the Resources tab) and join the Beyond The Scope community. All listeners are encouraged to use this forum to suggest future topics and guests, submit questions and corrections, and provide general feedback.

George Green, PhD | Bristol Myers Squibb 31:22 Share

Beyond the Scope

Shownotes Transcript

George Green, PhD | Bristol Myers Squibb